Page - (000264) - in Biomedical Chemistry: Current Trends and Developments

peptides. Journal of Pharmaceutical Sciences, 87, 283-288. Gupta, D.; Gupta, S. V.; Lee, K. D.; Amidon, G. D. (2009). Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers, Molecular Pharmaceutics, 6, 1604-1611. Green, M.; Loewenstein, P. M. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 55, 1179-1188. Grillo, M. A.; Colombatto, S. (2004). Arginine revisited: minireview article. Amino Acids, 26, 345- 351. Gynther, M.; Laine, K.; Ropponen, J.; Leppanen, J.; Mannila, A.; Nevalainen, T.; Savolainen, J.; Jarvinen, T.; Rautio, J. (2008). Large neutral amino acid transporter enables brain drug delivery via prodrugs. Journal of Medicinal Chemistry, 51, 932-936. Haas, H. L.; Sergeeva, O. A.; Selbach, O. (2008). Histamine in the nervous system. Physiology Review, 88, 1183-1241. Han, H.-K.; Amidom, G. L. (2010). Targeted prodrug design to optimize drug delivery. AAPS PharmaSci, 2, 48-58. Hamel, A. R.; Hubler, F.; Carrupt, A.; Wenger, R. M.; Mutter, M. (2004). Cyclosporin A prodrugs: design, synthesis and biophysical properties. Journal of Peptide Research, 63, 147-154. Han, H.; de Vrueh, R. L.; Rhie, J. K.; Covitz, K. M.; Smith, P. L.; Lee, C. P.; Oh, D. M.; Sadee, W.; Amidon, G. L. (1998). 5’-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharmacetical Research, 15, 1154- 1159. Hatanaka, T.; Haramura, M.; Fei, Y. J.; Miyauchi, S.; Bridges, C. C.; Ganapathy, P. S.; Smith, S. B.; Ganapathy, V.; Ganapathy, M. E. (2004). Transport of amino acid-based prodrugs by the Na+-and Cl(−) -coupled amino acid transporter ATB(0,+) and expression of the transporter in tissues amenable for drug delivery. Journal of Pharmacology and Experimental Therapeutics, 308, 1138-1147. Hauser, C. A.; Zhang, S. (2010). Designer self-assembling peptide nanofiber biological materials. Chemical Society Reviews, 39, 2780-2790. Hemenway, J. N.; Jarho, P.; Henri, J. T.; Nair, S. K.; VanderVelde, D.; Georg, G. I.; Stella, V. J. (2010). Preparation and physicochemical characterization of a novel water-soluble prodrug of carbamazepine. Journal of Pharmaceutical Sciences, 99, 1810-1825. Heitz, F.; Morris, M. C.; Divita, G. (2009). Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. British Journal of Pharmacology, 157, 195-206. Hervé, F.; Ghinea, N.; Scherrmann, J. M. (2008). CNS delivery via adsorptive transcytosis. AAPS Journal, 10, 455-472. Hofsteenge, J.; Capuano, A.; Altszuler, R.; Moore, S. (1986). Carrier-linked primaquine in the chemotherapy of malaria. Journal of Medicinal Chemistry, 29, 1765-1769. Hsiao, L. L.; Howard, R. J.; Aikawa, M.; Taraschi, T. F. (1991). Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria parasite Plasmodium falciparum. Biochemical Journal, 274, 121-132. Hsu, C. H.; Chen, C.; Jou, M. L.; Lee, A. Y.; Lin, Y. C.; Yu, Y. P.; Huang, W. T.; Wu S. H. (2005). Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Research, 33, 4053-4064.